ACCELERATE DIAGNOSTICS INC AXDX 2.5 03.15.23
NOTE 2.500% 3/1 · US DOMESTIC · CUSIP 00430HAB8
1
institutional holders
-1 vs Q1 2023
$0reported value*
0 new
0 added
0 reduced
1 sold out
net sold ≈ $2.8m
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 9 |
| Q4 2022 | 9 |
| Q1 2023 | 2 |
| Q2 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 1 |
| Q1 2023 | 0 | 7 |
| Q2 2023 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| Bruce & Co., Inc. | Sold out | -3.0m |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |